1-2 of 2
Borje S. Andersson
Close
Sort by
Journal Articles

Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities

Clinical Trials & Observations
Uday R. Popat, Oren Pasvolsky, Roland Bassett Jr., Rohtesh S. Mehta, Amanda Olson, Julianne Chen, Amin M. Alousi, Gheath Al-Atrash, Qaiser Bashir, Alison M. Gulbis, Chitra M. Hosing, Jin S. Im, Partow Kebriaei, Issa Khouri, David Marin, Yago Nieto, Betul Oran, Neeraj Saini, Terri Lynn Shigle, Samer A. Srour, Jeremy L. Ramdial, Katayoun Rezvani, Muzaffar H. Qazilbash, Borje S. Andersson, Richard E. Champlin, Elizabeth J. Shpall
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6196–6205.
https://doi.org/10.1182/bloodadvances.2023010850
Published: 2023
Includes: Supplemental data
Journal Articles

Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity

Clinical Trials & Observations
Ankur Varma, Susan C. Abraham, Rohtesh S. Mehta, Neeraj Y. Saini, Medhavi Honhar, Munazza Rashid, Julianne Chen, Samer A. Srour, Qaiser Bashir, Gabriela Rondon, Betul Oran, Chitra M. Hosing, Yago Nieto, Partow Kebriaei, Amin M. Alousi, Sairah Ahmed, David Marin, Issa F. Khouri, Stefan O. Ciurea, Muzaffar H. Qazilbash, Katy Rezvani, Paolo Anderlini, Borje S. Andersson, Elizabeth J. Shpall, Richard E. Champlin, Uday R. Popat
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1296–1306.
https://doi.org/10.1182/bloodadvances.2019000638
Published: 2020